Article
Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network.
JNCI cancer spectrum - 1 Aug 2021
Fan Xiao, Wynn Julia, Shang Ning, Liu Cong, Fedotov Alexander, Hallquist Miranda L G, Buchanan Adam H, Williams Marc S, Smith Maureen E, Hoell Christin, Rasmussen-Torvik Laura J, Peterson Josh F, Wiesner Georgia L, Murad Andrea M, Jarvik Gail P, Gordon Adam S, Rosenthal Elisabeth A, Stanaway Ian B, Crosslin David R, Larson Eric B, Leppig Kathleen A, Henrikson Nora B, Williams Janet L, Li Rongling, Hebbring Scott, Weng Chunhua, Shen Yufeng, Crew Katherine D, Chung Wendy K
Abstract excerpt
Background: Unbiased estimates of penetrance are challenging but critically important to make informed choices about strategies for risk management through increased surveillance and risk-reducing interventions. Methods: We studied the penetrance and clinical outcomes of 7 breast cancer susceptibility genes (BRCA1, BRCA2, TP53, CHEK2, ATM, PALB2, and PTEN) in almost 13 458 participants unselected for personal or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
